Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 1
2013 4
2014 5
2015 5
2018 2
2019 3
2020 1
2021 2
2022 3
2023 6
2024 4
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia.
Cappellini MD, Viprakasit V, Taher AT, Georgiev P, Kuo KHM, Coates T, Voskaridou E, Liew HK, Pazgal-Kobrowski I, Forni GL, Perrotta S, Khelif A, Lal A, Kattamis A, Vlachaki E, Origa R, Aydinok Y, Bejaoui M, Ho PJ, Chew LP, Bee PC, Lim SM, Lu MY, Tantiworawit A, Ganeva P, Gercheva L, Shah F, Neufeld EJ, Thompson A, Laadem A, Shetty JK, Zou J, Zhang J, Miteva D, Zinger T, Linde PG, Sherman ML, Hermine O, Porter J, Piga A; BELIEVE Investigators. Cappellini MD, et al. N Engl J Med. 2020 Mar 26;382(13):1219-1231. doi: 10.1056/NEJMoa1910182. N Engl J Med. 2020. PMID: 32212518 Clinical Trial.
Mitapivat in adults with non-transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE): a phase 3, international, randomised, double-blind, placebo-controlled trial.
Taher AT, Al-Samkari H, Aydinok Y, Besser M, Boscoe AN, Dahlin JL, De Luna G, Estepp JH, Gheuens S, Gilroy KS, Glenthøj A, Sim Goh A, Iyer V, Kattamis A, Loggetto SR, Morris S, Musallam KM, Osman K, Ricchi P, Salido-Fiérrez E, Sheth S, Tai F, Tevich H, Uhlig K, Urbstonaitis R, Viprakasit V, Cappellini MD, Kuo KHM; ENERGIZE investigators. Taher AT, et al. Lancet. 2025 Jul 5;406(10498):33-42. doi: 10.1016/S0140-6736(25)00635-X. Epub 2025 Jun 19. Lancet. 2025. PMID: 40544857 Clinical Trial.
A Little Known but Very Common Phenotype in Patients With Severe Congenital Neutropenia Due to HAX1 Deficiency: Premature Ovarian Insufficiency.
Kızılay DÖ, Karapınar DY, Karadaş N, Karaoğlan M, Akbayram S, Gökşen D, Gadashova A, Albayrak S, Şahinoğlu EP, Orbak Z, Bıçakçı Z, Akın L, Albayrak C, Koç C, Ünüvar A, Anık A, Aral YZ, Cimbek EA, Bahadır A, Mete C, Özen S. Kızılay DÖ, et al. Among authors: karadas n. Pediatr Blood Cancer. 2025 May;72(5):e31591. doi: 10.1002/pbc.31591. Epub 2025 Feb 21. Pediatr Blood Cancer. 2025. PMID: 39980410
Leukapheresis in childhood acute leukemias: single-center experience.
Yilmaz D, Karapinar B, Karadaş N, Duyu M, Yazici P, Ay Y, Balkan C, Aydinok Y, Kavakli K. Yilmaz D, et al. Among authors: karadas n. Pediatr Hematol Oncol. 2014 May;31(4):318-26. doi: 10.3109/08880018.2013.818747. Epub 2013 Aug 29. Pediatr Hematol Oncol. 2014. PMID: 23988130
Central nervous system thrombosis in pediatric acute lymphoblastic leukemia in Turkey: A multicenter study.
Guzelkucuk Z, Karapınar DY, Gelen SA, Tokgoz H, Ozcan A, Ay Y, Bahadır A, Ozbek NY, Oren AC, Ayhan AC, Akyay A, Akıncı B, Karadas N, Unuvar A, Oren H, Fettah A, Kaya Z, Isık B, Eker İ, Karaman S, Yıldırım AT, Orhan MF, Oymak Y, Timur C, Yazici N, Simsek A, Karakurt N, Toret E, Evim MS. Guzelkucuk Z, et al. Among authors: karadas n. Pediatr Blood Cancer. 2023 Aug;70(8):e30425. doi: 10.1002/pbc.30425. Epub 2023 May 17. Pediatr Blood Cancer. 2023. PMID: 37194482
35 results